Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century

Shraddha M. Dalwadi, Gary D. Lewis, Eric H. Bernicker, Edward Brian Butler, Bin S. Teh, Andrew M. Farach

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Racial disparities are historically profound and affect outcomes in early stage non–small-cell lung cancer. We aimed to explore if recent advances in radiotherapy and surgery have improved epidemiological differences in outcomes related to race. African American patients continued to do worse in a contemporary Surveillance, Epidemiology, and End Results data set, because of increased association with T2 disease, older age, squamous histology, male sex, and suboptimal treatment.

Original languageEnglish (US)
Pages (from-to)194-200
Number of pages7
JournalClinical Lung Cancer
Volume20
Issue number3
DOIs
StatePublished - May 2019

Keywords

  • Access
  • Race
  • SBRT
  • SEER
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint

Dive into the research topics of 'Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century'. Together they form a unique fingerprint.

Cite this